Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3375

Misleading promotion lands NJ drugmaker a letter from FDA

$
0
0
Edenbridge Pharmaceuticals received this year's first untitled letter from the FDA's drug promotion office over misleading claims in an advertisement for the company's multiple myeloma drug Hemady. The FDA said in ...

Viewing all articles
Browse latest Browse all 3375

Trending Articles